| Literature DB >> 29780228 |
Rasha H Soliman1, Mohammed I Oraby1, Mohammed Fathy2, Alaa M Essam1.
Abstract
BACKGROUND: Acute ischemic stroke is one of the major causes of disability and death worldwide. Effective prevention remains the best approach for reducing the burden of stroke. The aim of this work was to study the prevalence of stroke risk factors and the possible relation between such risk factors and the disease severity at presentation in a sample of stroke patients presented to Beni-Suef University Hospital, north Upper Egypt.Entities:
Keywords: Acute ischemic stroke; Beni-Suef; Risk factors; Stroke severity
Year: 2018 PMID: 29780228 PMCID: PMC5954772 DOI: 10.1186/s41983-018-0012-4
Source DB: PubMed Journal: Egypt J Neurol Psychiatr Neurosurg ISSN: 1110-1083
Distribution of risk factors in 167 studied ischemic stroke patients
| Risk factors | Number | Percent |
|---|---|---|
| Hypertension | 104 | 62.3 |
| Diabetes | 58 | 34.7 |
| Smoking | 69 | 41.3 |
| Alcohol intake | 0 | 0 |
| Positive family history | 23 | 13.8 |
| History of TIA | 9 | 5.4 |
| History of previous stroke | 46 | 27.5 |
| Stress | 9 | 5.4 |
| Obesity | 20 | 12 |
| Cardio-embolic | 60 | 35.9 |
| Significant carotid stenosis (≥ 50%) | 6 | 3.6 |
| Dyslipidemia | 97 | 58.1 |
| Migraine | 4 | 2.4 |
| Pregnancy and postpartum | 3 | 3.9 |
| Oral contraceptive | 2 | 12.5 |
Results of NIHSS and mRS in 167 ischemic stroke patients
| Scale | Score | Number (167) | Percent |
|---|---|---|---|
| NIHSS | Mild (1–4) | 33 | 19.8 |
| Moderate (5–15) | 103 | 61.7 | |
| Moderate to severe (16–20) | 19 | 11.4 | |
| Severe (21–42) | 12 | 7.2 | |
| mRS | 0 | 0 | 0 |
| 1 | 6 | 3.6 | |
| 2 | 22 | 13.2 | |
| 3 | 43 | 25.7 | |
| 5 | 29 | 17.4 | |
| 6 | 0 | 0 |
Results of cardiological assessment in 167 ischemic stroke patients
| Cardiac risk factors | Number (167) | Percent |
|---|---|---|
| Rheumatic heart disease | 36 | 21.6 |
| Atrial fibrillation | 44 | 26.3 |
| Atrial myxoma | 1 | 0.6 |
| Prosthetic valve | 3 | 1.8 |
| Mural thrombus | 3 | 1.8 |
| Ischemic heart disease | 15 | 9 |
| Left ventricular hypertrophy | 51 | 30.5 |
Distribution of additional risk factors in 12 ischemic stroke patients ≤ 45 years old
| Risk factors | Total number = 12 | |
|---|---|---|
| Number | Percent | |
| Auto-immune vasculitis | 0 | 0 |
| Antiphospholipid syndrome | 1 | 8.3 |
| Protein C deficiency | 2 | 16.7 |
| Protein S deficiency | 1 | 8.3 |
| Antithrombin III deficiency | 0 | 0 |
| Factor V Leiden mutation | 9 | 75.0 |
| Patent foramen ovale | 1 | 8.3 |
| Undetermined | 1 | 8.3 |
Relation between non-modifiable risk factors and stroke severity and disability at presentation using NIHSS and mRS
| Risk factors | NIHSS | mRS | ||
|---|---|---|---|---|
| Mean ± standard deviation | Mean ± standard deviation | |||
| Age | ||||
| 15–45 | 8.25 ± 4.84 | 0.092 | 2.75 ± 0.99 | < 0.001* |
| 46–90 | 10.58 ± 5.92 | 3.71 ± 0.97 | ||
| Sex | ||||
| Male | 10.01 ± 6.29 | 0.343 | 3.49 ± 1.06 | 0.359 |
| Female | 10.52 ± 5.26 | 3.66 ± 0.98 | ||
| Family history | ||||
| +ve | 10.09 ± 5.45 | 0.909 | 3.35 ± 1.15 | 0.296 |
| −ve | 10.27 ± 5.90 | 3.60 ± 1.01 | ||
| History of TIA | ||||
| Yes | 10.33 ± 4.39 | 0.725 | 4.00 ± 0.71 | 0.215 |
| No | 10.24 ± 5.91 | 3.54 ± 1.04 | ||
| History of previous stroke | ||||
| Yes | 10.67 ± 5.19 | 0.316 | 3.83 ± 0.80 | 0.063 |
| No | 10.08 ± 6.06 | 3.47 ± 1.09 | ||
| Pregnancy and postpartum | ||||
| Yes | 6.33 ± 5.77 | 0.364 | 2.67 ± 1.15 | 0.439 |
| No | 9.00 ± 4.71 | 3.15 ± 0.99 | ||
*P is significant if < 0.05
Relation between modifiable risk factors and ischemic stroke severity and disability at presentation using NIHSS and mRS
| Risk factor | NIHSS | mRS | ||
|---|---|---|---|---|
| Mean ± standard deviation | Mean ± standard deviation | |||
| Hypertension | ||||
| Yes | 11.05 ± 5.91 | 0.023* | 3.80 ± 0.94 | < 0.001* |
| No | 8.92 ± 5.48 | 3.19 ± 1.06 | ||
| Diabetes mellitus | ||||
| Yes | 9.43 ± 5.18 | 0.221 | 3.60 ± 0.97 | 0.927 |
| No | 10.68 ± 6.12 | 3.55 ± 1.06 | ||
| Smoking | ||||
| Yes | 10.29 ± 6.37 | 0.766 | 3.57 ± 1.01 | 0.901 |
| No | 10.21 ± 5.45 | 3.57 ± 1.05 | ||
| Obesity | ||||
| Yes | 10.15 ± 6.97 | 0.634 | 3.30 ± 1.17 | 0.211 |
| No | 10.26 ± 5.68 | 3.61 ± 1 | ||
| Cardio-embolic | ||||
| Yes | 11.52 ± 6.64 | 0.085 | 3.75 ± 1.10 | 0.044* |
| No | 9.53 ± 5.21 | 3.47 ± 0.97 | ||
| Carotid stenosis | ||||
| ≥ 50% | 17.17 ± 6.31 | 0.011* | 4.50 ± .55 | 0.017* |
| < 50% | 9.99 ± 5.67 | 3.53 ± 1.2 | ||
| Dyslipidemia | ||||
| Yes | 10.33 ± 5.88 | 0.834 | 3.28 ± 1.16 | 0.201 |
| No | 10.13 ± 5.79 | 3.58 ± 1.01 | ||
*P is significant if < 0.05
Relation between potentially modifiable risk factors and ischemic stroke severity and disability at presentation using NIHSS and mRS
| Risk factor | NIHSS | mRS | ||
|---|---|---|---|---|
| Mean ± standard deviation | Mean ± standard deviation | |||
| Migraine | ||||
| Yes | 7.50 ± 6.61 | 0.266 | 3.00 ± 1.41 | 0.265 |
| No | 10.31 ± 5.81 | 3.58 ± 1.02 | ||
| Antiphospholipid syndrome | ||||
| Yes | 16.00 | 0.333 | 3.00 | 0.833 |
| No | 7.82 ± 4.87 | 2.55 ± 0.93 | ||
| Factor V Leiden mutation | ||||
| Yes | 8.00 ± 5.41 | 0.600 | 2.44 ± 1.01 | 0.482 |
| No | 10.00 ± 5.29 | 3.00 ± 0.00 | ||
| Protein C | ||||
| Normal | 9.60 ± 5.02 | 0.121 | 2.80 ± 0.79 | 0.121 |
| Deficient | 3.00 | 1.50 ± 0.71 | ||
| Protein S | ||||
| Normal | 9.00 ± 5.16 | 0.333 | 2.64 ± 0.92 | 0.500 |
| Deficient | 3.00 | 2.00 | ||